Clinical Trial Update: Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating Amla for metabolic syndrome, focusing on insulin sensitivity and insulin secretion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Amla

Snippet

Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome | Phase 2, Phase 3 | Status: COMPLETED